23andMe SPAC Presentation Deck

World Class Leadership Team Merging Tech, Biotech and Healthcare Consumer Anne Wojcicki Co-Founder and Chief Executive Officer KAISER PERMANENTE BERNARD J TYSON SCHOOL OF MEDICINE Kumar lyer Head of Product Previously at Facebook, Netflix Yale investor Steve Lemon VP, Engineering Previously at Loopt, WebMD, Apple Tracy Keim VP, Consumer, Marketing & Brand Previously at RAPP, Bonobos, Volvo Okey Onyejekwe, MD, JD VP, Healthcare Ops & Medical Affairs Previously at Veterans Health, U.S. Air Force, Virta Steve Schoch Chief Financial Officer MIRAMAX AMGEN Research & Corporate Joyce Tung, PhD VP, Research Previously at Stanford University, UCSF Jacquie Haggarty, MPP, JD VP, Deputy General Counsel & Privacy Officer Previously at Genomic Health, Latham & Watkins David Baker Chief Security Officer Previously at Okta, Bugcrowd Kathy Hibbs, JD Chief Legal & Regulatory Officer Genomic Health LIFE, CHANGING Therapeutics Monogram BIOSCIENCES Lap Jennifer Low, MD, PhD Head of Therapeutics Development Previously at Loxo, Genentech Adam Auton, PhD VP, Human Genetics Previously at Albert Einstein College of Medicine, University of Oxford Monica Viziano, PhD VP, Portfolio Strategy & Alliance Management Previously at GSK, Gilead Richard Scheller, PhD Board Director (former Chief Science Officer) Previously at Genentech, Stanford University Kenneth Hillan, M.B., Ch.B. Head of Therapeutics ACHAOGEN Genentech Select Investors Virgin NEW VIEW Genentech CAPITAL Fidelity INVESTMENTS gsk Google CASDIN CAPITAL LIFE SCIENCE INVESTMENTS SEQUOIA g G SQUARED 23andMe Confidential and Proprietary Information 8

View entire presentation